PURPOSE: We evaluated the controlled release of lysozyme from various poly(D,L-lactic-co-glycolic acid) (PLGA) 50/50-polyethylene glycol (PEG) block copolymers relative to PLGA 50/50. METHODS: Lysozyme was encapsulated in cylindrical implants (0.8 mm diameter) by a solvent extrusion method. Release studies were conducted in phosphate buffered saline +0.02% Tween 80 (PBST) at 37°C. Lysozyme activity was measured by a fluorescence-based assay. Implant erosion was evaluated by kinetics of polymer molecular weight decline, water uptake, and mass loss. RESULTS: Lysozyme release from an AB15 di-block copolymer (15% 5 kDa PEG, PLGA 28 kDa) was very fast, whereas an AB10 di-block copolymer (with 10% 5 kDa PEG, PLGA 45 kDa) and ABA10 tri-block copolymer (with 10% 6 kDa PEG, PLGA 27 kDa) showed release profiles similar to PLGA. We achieved continuous lysozyme release for up to 4 weeks from AB10 and ABA10 by lysozyme co-encapsulation with the pore-forming and acid-neutralizing MgCO3, and from AB15 by co-encapsulation of MgCO3 and blending AB15 with PLGA. Lysozyme activity was mostly recovered during 4 weeks. CONCLUSIONS: These block co-polymers may have utility either alone or as PLGA blends for the controlled release of proteins.
PURPOSE: We evaluated the controlled release of lysozyme from various poly(D,L-lactic-co-glycolic acid) (PLGA) 50/50-polyethylene glycol (PEG) block copolymers relative to PLGA 50/50. METHODS: Lysozyme was encapsulated in cylindrical implants (0.8 mm diameter) by a solvent extrusion method. Release studies were conducted in phosphate buffered saline +0.02% Tween 80 (PBST) at 37°C. Lysozyme activity was measured by a fluorescence-based assay. Implant erosion was evaluated by kinetics of polymer molecular weight decline, water uptake, and mass loss. RESULTS: Lysozyme release from an AB15 di-block copolymer (15% 5 kDa PEG, PLGA 28 kDa) was very fast, whereas an AB10 di-block copolymer (with 10% 5 kDa PEG, PLGA 45 kDa) and ABA10 tri-block copolymer (with 10% 6 kDa PEG, PLGA 27 kDa) showed release profiles similar to PLGA. We achieved continuous lysozyme release for up to 4 weeks from AB10 and ABA10 by lysozyme co-encapsulation with the pore-forming and acid-neutralizing MgCO3, and from AB15 by co-encapsulation of MgCO3 and blending AB15 with PLGA. Lysozyme activity was mostly recovered during 4 weeks. CONCLUSIONS: These block co-polymers may have utility either alone or as PLGA blends for the controlled release of proteins.
Authors: Yanqiang Zhong; Li Zhang; Amy G Ding; Anna Shenderova; Gaozhong Zhu; Ping Pei; Ruth R Chen; Susan R Mallery; David J Mooney; Steven P Schwendeman Journal: J Control Release Date: 2007-05-23 Impact factor: 9.776
Authors: Oliver C Rogers; Lizamma Antony; Oren Levy; Nitin Joshi; Brian W Simons; Susan L Dalrymple; D Marc Rosen; Andrew Pickering; Haoyue Lan; Heidi Kuang; Sudhir H Ranganath; Lei Zheng; Jeffrey M Karp; S Peter Howard; Samuel R Denmeade; John T Isaacs; W Nathaniel Brennen Journal: Mol Cancer Ther Date: 2020-09-17 Impact factor: 6.261
Authors: Chih-Yuan Chiang; Ricky L Ulrich; Melanie P Ulrich; Brett Eaton; Jenifer F Ojeda; Douglas J Lane; Krishna P Kota; Tara A Kenny; Jason T Ladner; Samuel P Dickson; Kathleen Kuehl; Rahul Raychaudhuri; Mei Sun; Sina Bavari; Mark J Wolcott; David Covell; Rekha G Panchal Journal: BMC Microbiol Date: 2015-11-06 Impact factor: 3.605